BIOMARIN PHARMACEUTICAL INC·4

Dec 5, 4:56 PM ET

FUCHS HENRY J 4

4 · BIOMARIN PHARMACEUTICAL INC · Filed Dec 5, 2023

Insider Transaction Report

Form 4
Period: 2023-12-01
FUCHS HENRY J
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2023-04-28$66.88/sh+317$21,200176,504 total
  • Award

    Common Stock

    2023-12-01+17,750194,254 total
Footnotes (2)
  • [F1]Represents the shares acquired by the reporting person on April 28, 2023, pursuant to the issuer's Employee Stock Purchase Plan.
  • [F2]Restricted stock units granted on December 1, 2023. Price not applicable.

Documents

3 files